HROW
Harrow Health, Inc.$40.23-1.23 (-2.97%)Prev Close$41.41·MCap$1.44B·P/E—·Vol335.4K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
5
$17.98M
◆
Net Activity
Net Seller
$17.98M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Harrow Health, Inc. (HROW) has been exclusively selling, with 0 insider purchases totaling $0.00 and 5 insider sales totaling $17.98M. The most recent insider transaction was by Opaleye Management Inc. (10 percent owner), who sold $270.9K worth of shares on Mar 3, 2026. Harrow Health, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $1.44B.
HROW Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Opaleye Management Inc. | 10 percent owner | Sell | 5,000 | $54.18 | $270.9K | 65,000 |
| Jan 8, 2026 | Opaleye Management Inc. | 10 percent owner | Sell | 20,000 | $53.35 | $1.07M | 70,000 |
| Dec 12, 2025 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | Sell | 79,994 | $47.06 | $3.76M | 0 |
| Dec 12, 2025 | BOLL ANDREW R. | PRESIDENT AND CFO | Sell | 26,665 | $47.06 | $1.25M | 0 |
| Jul 21, 2025 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | Sell | 313,338 | $37.08 | $11.62M0.8% OS | 0 |
| Apr 3, 2025 | BAUM MARK L | Chief Executive Officer | Sell | 300,363 | $23.09 | $6.94M0.8% OS | 0 |
| Apr 3, 2025 | BOLL ANDREW R. | Chief Financial Officer | Sell | 136,745 | $23.09 | $3.16M | 0 |
| Apr 3, 2025 | SAHAREK JOHN P. | CEO & President, ImprimisRx | Sell | 109,475 | $23.09 | $2.53M | 0 |
| Jan 24, 2025 | Opaleye Management Inc. | 10% Owner | Sell | 20,000 | $35.59 | $711.8K | 155,000 |
| Apr 25, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $9.97 | $199.4K | 3,815,000 |
| Apr 24, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $10.23 | $204.6K | 3,795,000 |
| Apr 19, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 29,400 | $10.56 | $310.4K | 3,775,000 |
| Mar 28, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 50,000 | $12.82 | $641.0K | 3,745,600 |
| Mar 25, 2024 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | Buy | 9,000 | $11.59 | $104.3K | 2,137,525 |
| Mar 22, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 50,600 | $9.65 | $488.3K | 3,695,600 |
| Nov 16, 2023 | BAUM MARK L | Chief Executive Officer | Buy | 7,500 | $8.11 | $60.8K | 2,022,961 |
| Nov 16, 2023 | Opaleye Management Inc. | 10% Owner | Buy | 25,000 | $8.03 | $200.7K | 3,645,000 |
| Sep 20, 2023 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $14.60 | $292.1K | 3,620,000 |
| Aug 15, 2023 | BAUM MARK L | Chief Executive Officer | Buy | 5,800 | $17.05 | $98.9K | 2,015,461 |
| Aug 15, 2023 | Makary Martin A. | Director | Buy | 20,000 | $16.92 | $338.4K | 45,000+80% |
| Dec 23, 2022 | BAUM MARK L | Chief Executive Officer | Buy | 25,000 | $13.39 | $334.8K | 1,432,141 |
| Dec 23, 2022 | BOLL ANDREW R. | Chief Financial Officer | Buy | 2,500 | $13.54 | $33.9K | 255,063 |
| Dec 23, 2022 | Makary Martin A. | Director | Buy | 25,000 | $13.37 | $334.3K | 25,000 |
| Dec 23, 2022 | Van Horn R. Lawrence | Director | Buy | 1,860 | $13.42 | $25.0K | 1,860 |
| Dec 14, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 431,183 | $10.52 | $4.54M1.2% OS | 3,600,000 |
| Oct 3, 2022 | LINDSTROM RICHARD L MD | Director | Sell | 40,000 | $12.62 | $504.8K | 26,100-61% |
| Sep 30, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 11,085 | $9.77 | $108.4K | 3,185,000 |
| Apr 13, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 41,389 | $6.75 | $279.5K | 3,175,000 |
| Jan 31, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 6,343 | $6.89 | $43.7K | 3,140,000 |
| Sep 27, 2021 | LINDSTROM RICHARD L MD | Director | Sell | 3,900 | $10.04 | $39.2K | 66,100 |
| Sep 17, 2021 | LINDSTROM RICHARD L MD | Director | Sell | 20,000 | $9.07 | $181.4K | 75,840 |
| Aug 23, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 52,500 | $8.45 | $443.4K | 3,135,000 |
| Aug 19, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 72,500 | $8.62 | $624.7K | 3,085,000 |
| Jul 22, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $7.31 | $146.3K | 3,015,000 |
| Jun 22, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 74,584 | $8.34 | $622.4K | 3,000,000 |
| May 21, 2021 | LINDSTROM RICHARD L MD | Director | Sell | 10,000 | $10.75 | $107.5K | 90,000 |
| Apr 12, 2021 | HARROW HEALTH, INC. | 10% Owner | Sell | 1,518,000 | $7.00 | $10.63M4.1% OS | 1,982,000-43% |
HROW Insider Buying Activity
The following table shows recent insider purchases of Harrow Health, Inc. (HROW) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 25, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $9.97 | $199.4K | 3,815,000 |
| Apr 24, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $10.23 | $204.6K | 3,795,000 |
| Apr 19, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 29,400 | $10.56 | $310.4K | 3,775,000 |
| Mar 28, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 50,000 | $12.82 | $641.0K | 3,745,600 |
| Mar 25, 2024 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | Buy | 9,000 | $11.59 | $104.3K | 2,137,525 |
| Mar 22, 2024 | Opaleye Management Inc. | 10% Owner | Buy | 50,600 | $9.65 | $488.3K | 3,695,600 |
| Nov 16, 2023 | BAUM MARK L | Chief Executive Officer | Buy | 7,500 | $8.11 | $60.8K | 2,022,961 |
| Nov 16, 2023 | Opaleye Management Inc. | 10% Owner | Buy | 25,000 | $8.03 | $200.7K | 3,645,000 |
| Sep 20, 2023 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $14.60 | $292.1K | 3,620,000 |
| Aug 15, 2023 | BAUM MARK L | Chief Executive Officer | Buy | 5,800 | $17.05 | $98.9K | 2,015,461 |
| Aug 15, 2023 | Makary Martin A. | Director | Buy | 20,000 | $16.92 | $338.4K | 45,000+80% |
| Dec 23, 2022 | BAUM MARK L | Chief Executive Officer | Buy | 25,000 | $13.39 | $334.8K | 1,432,141 |
| Dec 23, 2022 | BOLL ANDREW R. | Chief Financial Officer | Buy | 2,500 | $13.54 | $33.9K | 255,063 |
| Dec 23, 2022 | Makary Martin A. | Director | Buy | 25,000 | $13.37 | $334.3K | 25,000 |
| Dec 23, 2022 | Van Horn R. Lawrence | Director | Buy | 1,860 | $13.42 | $25.0K | 1,860 |
| Dec 14, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 431,183 | $10.52 | $4.54M1.2% OS | 3,600,000 |
| Sep 30, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 11,085 | $9.77 | $108.4K | 3,185,000 |
| Apr 13, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 41,389 | $6.75 | $279.5K | 3,175,000 |
| Jan 31, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 6,343 | $6.89 | $43.7K | 3,140,000 |
| Aug 23, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 52,500 | $8.45 | $443.4K | 3,135,000 |
| Aug 19, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 72,500 | $8.62 | $624.7K | 3,085,000 |
| Jul 22, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $7.31 | $146.3K | 3,015,000 |
| Jun 22, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 74,584 | $8.34 | $622.4K | 3,000,000 |
HROW Insider Selling Activity
The following table shows recent insider sales of Harrow Health, Inc. (HROW) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Opaleye Management Inc. | 10 percent owner | Sell | 5,000 | $54.18 | $270.9K | 65,000 |
| Jan 8, 2026 | Opaleye Management Inc. | 10 percent owner | Sell | 20,000 | $53.35 | $1.07M | 70,000 |
| Dec 12, 2025 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | Sell | 79,994 | $47.06 | $3.76M | 0 |
| Dec 12, 2025 | BOLL ANDREW R. | PRESIDENT AND CFO | Sell | 26,665 | $47.06 | $1.25M | 0 |
| Jul 21, 2025 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | Sell | 313,338 | $37.08 | $11.62M0.8% OS | 0 |
| Apr 3, 2025 | BAUM MARK L | Chief Executive Officer | Sell | 300,363 | $23.09 | $6.94M0.8% OS | 0 |
| Apr 3, 2025 | BOLL ANDREW R. | Chief Financial Officer | Sell | 136,745 | $23.09 | $3.16M | 0 |
| Apr 3, 2025 | SAHAREK JOHN P. | CEO & President, ImprimisRx | Sell | 109,475 | $23.09 | $2.53M | 0 |
| Jan 24, 2025 | Opaleye Management Inc. | 10% Owner | Sell | 20,000 | $35.59 | $711.8K | 155,000 |
| Oct 3, 2022 | LINDSTROM RICHARD L MD | Director | Sell | 40,000 | $12.62 | $504.8K | 26,100-61% |
| Sep 27, 2021 | LINDSTROM RICHARD L MD | Director | Sell | 3,900 | $10.04 | $39.2K | 66,100 |
| Sep 17, 2021 | LINDSTROM RICHARD L MD | Director | Sell | 20,000 | $9.07 | $181.4K | 75,840 |
| May 21, 2021 | LINDSTROM RICHARD L MD | Director | Sell | 10,000 | $10.75 | $107.5K | 90,000 |
| Apr 12, 2021 | HARROW HEALTH, INC. | 10% Owner | Sell | 1,518,000 | $7.00 | $10.63M4.1% OS | 1,982,000-43% |
HROW Insiders
Similar Stocks to HROW
ZTS
Zoetis Inc.
$117.47-0.31%
$51.80B
VTRS
Viatris Inc.
$14.70-0.73%
$17.15B
NBIX
Neurocrine Biosciences, Inc.
$127.75-0.23%
$13.07B
INDV
Indivior Pharmaceuticals Inc
$34.44+0.36%
$4.15B
SUPN
Supernus Pharmaceuticals, Inc.
$48.30-2.35%
$2.87B
PAHC
Phibro Animal Health Corporation
$54.56-2.81%
$2.19B
ANIP
ANI Pharmaceuticals, Inc.
$78.47-1.42%
$1.79B
PRGO
Perrigo Company plc
$11.57+0.74%
$1.61B